Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A, HNF1B)
United Therapeutics Europe Ltd
Maturity-onset Diabetes of the Young
1 trial -
Genotype detected through GenSeizer high-throughput gene capture technology
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non - Tuberculosis Mycobacteria Lung Disease
1 trial -
Group A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Crohn Disease
1 trial -
Group A (clinical guideline+machine learning)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
Group S: sugammadex injection
Hospital Authority, Hong Kong
Head and Neck Surgery
1 trial -
Guben Kechuan Granules group
Universal Integrated
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
Health education and conservative management of clinical routines
The First People's Hospital of Lianyungang
Recurrent Acute Pancreatitis
1 trial -
High risk experimental group
The First People's Hospital of Lianyungang
Adolescent Idiopathic Scoliosis
1 trial -
Hou Gu Mi Xi
Universal Integrated
Gastrointestinal Disease
1 trial -
House dust mite
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Allergic Asthma
1 trial -
Hyaluronic Acid
Hospital Authority, Hong Kong
Shoulder Pain
1 trial -
IMIQUIMOD cream 50mg/g
BRIGHT MINDS BIOSCIENCES INC.
Cutaneous Lupus Erythematosus
1 trial -
Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
Infant and young child feeding
United Therapeutics Europe Ltd
Growth; Stunting, Nutritional
1 trial -
Intensive BP treatment group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
Intravenous Anesthetic Induction with Ciprofol for Painless Colonoscopy in Elderly Patients
The First People's Hospital of Lianyungang
Ciprofol
1 trial -
Intravenous Nicotine
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Intravenous Vitamin C
United Therapeutics Europe Ltd
Burns
1 trial -
Intravenous administration of ferric carboxymaltose
United Therapeutics Europe Ltd
Lung Hypoxia
1 trial -
Intravenous dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aneurysm Cerebral
1 trial -
Intravenous sedation
United Therapeutics Europe Ltd
Lower Back Pain
1 trial -
Intravenous thrombolysis
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
Intravenous tramadol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Catheter Site Discomfort
1 trial -
Jianpixiaozhong particles and Wuse Dietotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Idiopathic Membranous Nephropathy
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources